The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Vasotop 0.625 mg tablets



Intervet Ireland LimitedVPA10996/138/004

Main Information

Trade NameVasotop 0.625 mg tablets
Active SubstancesRamipril
Dosage FormTablet
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/138/004

Group Information

ATC CodeQC09AA05 ramipril
Therapeutic ClassCardiovascular
SpeciesDogs

Status

License statusAuthorised
Licence Issued28/10/2005
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back